Status:
WITHDRAWN
Effect of Cataract Hyperemulsification Surgery on Meibomian Gland Morphology and Function
Lead Sponsor:
Yune Zhao
Conditions:
Meibomian Gland Dysfunction
Eligibility:
All Genders
38-87 years
Brief Summary
50 participants at Eye Hospital of Wenzhou Medical University during August, 2017 to July, 2020 will be enrolled in this study. To study the effect of cataract supermammary surgery on the morphology a...
Eligibility Criteria
Inclusion
- Previously untreated patients with xerophthalmia
- Undergoing cataract hyperemulsification surgery
Exclusion
- No history of ocular surgery and trauma
- Any eye diseases except xerophthalmia
- No treated for xerophthalmia before
- Successful completion of follow-ups
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04667871
Start Date
August 1 2017
End Date
September 1 2020
Last Update
December 16 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.